Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB.
Schelker RC, Andrulis M, Müller G, Ushmorov A, Hart C, Herr W, Vogelhuber M, Iberl S, Grassinger J. Schelker RC, et al. Among authors: iberl s. Blood Cells Mol Dis. 2019 May;76:78-81. doi: 10.1016/j.bcmd.2019.02.005. Epub 2019 Feb 20. Blood Cells Mol Dis. 2019. PMID: 30827761 No abstract available.
Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients.
Johannesen S, Budeus B, Peters S, Iberl S, Meyer AL, Kammermaier T, Wirkert E, Bruun TH, Samara VC, Schulte-Mattler W, Herr W, Schneider A, Grassinger J, Bogdahn U. Johannesen S, et al. Among authors: iberl s. Front Neurol. 2018 Nov 26;9:971. doi: 10.3389/fneur.2018.00971. eCollection 2018. Front Neurol. 2018. PMID: 30534107 Free PMC article.
Modeling and Bioinformatics Identify Responders to G-CSF in Patients With Amyotrophic Lateral Sclerosis.
Johannesen S, Huie JR, Budeus B, Peters S, Wirth AM, Iberl S, Kammermaier T, Kobor I, Wirkert E, Küspert S, Tahedl M, Grassinger J, Pukrop T, Schneider A, Aigner L, Schulte-Mattler W, Schuierer G, Koch W, Bruun TH, Ferguson AR, Bogdahn U. Johannesen S, et al. Among authors: iberl s. Front Neurol. 2021 Mar 18;12:616289. doi: 10.3389/fneur.2021.616289. eCollection 2021. Front Neurol. 2021. PMID: 33815246 Free PMC article.
D-2-hydroxyglutarate supports a tolerogenic phenotype with lowered major histocompatibility class II expression in non-malignant dendritic cells and acute myeloid leukemia cells.
Hammon K, Renner K, Althammer M, Voll F, Babl N, Decking SM, Siska PJ, Matos C, Conejo ZEC, Mendes K, Einwag F, Siegmund H, Iberl S, Berger RS, Dettmer K, Schoenmehl R, Brochhausen C, Herr W, Oefner PJ, Rehli M, Thomas S, Kreutz M. Hammon K, et al. Among authors: iberl s. Haematologica. 2024 Aug 1;109(8):2500-2514. doi: 10.3324/haematol.2023.283597. Haematologica. 2024. PMID: 38235501 Free PMC article.
11 results